These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31935842)

  • 21. Biosynthetic origin of mycobacterial cell wall galactofuranosyl residues.
    Weston A; Stern RJ; Lee RE; Nassau PM; Monsey D; Martin SL; Scherman MS; Besra GS; Duncan K; McNeil MR
    Tuber Lung Dis; 1997; 78(2):123-31. PubMed ID: 9692181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential inhibitors for mycobacterial uridine diphosphogalactofuranose-galactopyranose mutase enzyme: A novel drug target through in silico approach.
    Nayak T; Jena L; Waghmare P; Harinath BC
    Int J Mycobacteriol; 2018; 7(1):61-68. PubMed ID: 29516888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis.
    Bhat ZS; Rather MA; Maqbool M; Lah HU; Yousuf SK; Ahmad Z
    Biomed Pharmacother; 2017 Nov; 95():1520-1534. PubMed ID: 28946393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell wall core galactofuran synthesis is essential for growth of mycobacteria.
    Pan F; Jackson M; Ma Y; McNeil M
    J Bacteriol; 2001 Jul; 183(13):3991-8. PubMed ID: 11395463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection.
    Mohareer K; Asalla S; Banerjee S
    Tuberculosis (Edinb); 2018 Dec; 113():99-121. PubMed ID: 30514519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Novel Inhibitors of UDP-Galactopyranose Mutase by Structure-Based Virtual Screening.
    Karunan Partha S; Sadeghi-Khomami A; Cren S; Robinson RI; Woodward S; Slowski K; Berast L; Zheng B; Thomas NR; Sanders DA
    Mol Inform; 2011 Oct; 30(10):873-83. PubMed ID: 27468107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development.
    Moraes GL; Gomes GC; Monteiro de Sousa PR; Alves CN; Govender T; Kruger HG; Maguire GE; Lamichhane G; Lameira J
    Tuberculosis (Edinb); 2015 Mar; 95(2):95-111. PubMed ID: 25701501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamins Based Novel Target Pathways/Molecules as Possible Emerging Drug Targets for the Management of Tuberculosis.
    Sharma A; Jain K; Flora SJS
    Med Chem; 2018; 14(3):212-224. PubMed ID: 29110620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future target-based drug discovery for tuberculosis?
    Kana BD; Karakousis PC; Parish T; Dick T
    Tuberculosis (Edinb); 2014 Dec; 94(6):551-6. PubMed ID: 25458615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Biotin Biosynthetic Pathway in Mycobacterium tuberculosis is a Validated Target for the Development of Antibacterial Agents.
    Bockman MR; Mishra N; Aldrich CC
    Curr Med Chem; 2020; 27(25):4194-4232. PubMed ID: 30663561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel galactosyl transferase involved in biosynthesis of the mycobacterial cell wall.
    Mikusová K; Belánová M; Korduláková J; Honda K; McNeil MR; Mahapatra S; Crick DC; Brennan PJ
    J Bacteriol; 2006 Sep; 188(18):6592-8. PubMed ID: 16952951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
    Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
    J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology.
    Chandra P; Rajmani RS; Verma G; Bhavesh NS; Kumar D
    mSphere; 2016; 1(2):. PubMed ID: 27303736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium tuberculosis chorismate mutase: A potential target for TB.
    Khanapur M; Alvala M; Prabhakar M; Shiva Kumar K; Edwin RK; Sri Saranya PS; Patel RK; Bulusu G; Misra P; Pal M
    Bioorg Med Chem; 2017 Mar; 25(6):1725-1736. PubMed ID: 28202315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Second, Druggable Binding Site in UDP-Galactopyranose Mutase from Mycobacterium tuberculosis?
    Shi Y; Colombo C; Kuttiyatveetil JR; Zalatar N; van Straaten KE; Mohan S; Sanders DA; Pinto BM
    Chembiochem; 2016 Dec; 17(23):2264-2273. PubMed ID: 27653508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.